Johnson & Johnson Marks More Than 2 Billion Doses of Medicine Donated to Date to Help Combat Intestinal Worms
NEW BRUNSWICK, N.J., January 27, 2022 – In advance of World Neglected Tropical Diseases (NTD) Day on January 30, Johnson & Johnson is pleased to announce it has now donated a total of more than 2 billion doses of mebendazole, its medicine to treat intestinal worm infections, to people in need in more than 50 resource-limited countries worldwide. This marks the latest achievement in Johnson & Johnson’s longstanding donation program aimed at helping children, who are especially vulnerable to intestinal worms, live healthier lives. “More than fifteen years ago, Johnson & Johnson committed to addr...
Source: Johnson and Johnson - January 27, 2022 Category: Pharmaceuticals Source Type: news

A Newly Published Network Meta-Analysis (NMA) Found TREMFYA ® (guselkumab) Ranked Highest for Overall Level of Skin Clearance and Provided Positive Joint Efficacy Among Active Psoriatic Arthritis (PsA) Therapies
Conclusions (i.e., comparable) are based on an overlap of pairwise 95 percent credible intervals.1c. PASI 90 is defined as at least 90 percent improvement from baseline in the PASI score. The PASI score grades the amount of surface area on each body region that is covered by PsO plaques and the severity of plaques for their redness, thickness, and scaliness.13 PASI 90 was not a controlled endpoint in DISCOVER-1 or -2.8,9d. TREMFYA q4w dosing is not currently FDA-approved.2e. The PsA-modified vdH-S score combines erosion and joint space narrowing scores derived from radiographs of joints in body regions impacted by PsA.14 T...
Source: Johnson and Johnson - January 26, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Psychotropic Medication Use Linked to Mortality in Cardiac Patients
WEDNESDAY, Jan. 26, 2022 -- For cardiac patients, use of psychotropic medication is associated with increased mortality, according to a study recently published in the European Journal of Cardiovascular Nursing. Pernille Fevejle Cromhout, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 26, 2022 Category: Pharmaceuticals Source Type: news

High cholesterol: The snack that could slash bad levels by 30% in days - 'rapid results'
HIGH cholesterol and its treatments have become an indispensable tool in the fight against cardiovascular disease. But while statins confer strong effects, researchers are adamant that diet is equally useful. In recent developments, a new approach has been shown to offer "highly significant" results in just days. (Source: Daily Express - Health)
Source: Daily Express - Health - January 26, 2022 Category: Consumer Health News Source Type: news

How to live longer: Best type of bread reducing both cardiovascular disease & cancer risk
LONG life expectancy will almost always come down to one's daily habits. This should not entail a life of deprivation, however. In fact, enjoying delicious bread in moderation has been shown to reduce cardiovascular diseases and lowering cholesterol. The key is the right kind of bread. What is it? (Source: Daily Express - Health)
Source: Daily Express - Health - January 25, 2022 Category: Consumer Health News Source Type: news

Management of hydrocarbon burns: considering mental health and biochemical abnormalities - Rudduck EL, Concannon E, Coghlan P, Govindan T, Kurmis R, Solanki N.
Volatile substance misuse, particularly the inhalation of hydrocarbons, is a growing issue globally. Consequences of VSM, both acute or chronic, causes cardiovascular, respiratory, renal, metabolic and central nervous system damage. Whilst the effects of h... (Source: SafetyLit)
Source: SafetyLit - January 21, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Deborah Nickerson, Pioneering Genome Researcher, Dies at 67
Using the Human Genome Project as her guide, she helped find genes responsible for cardiovascular disease, autism and a rare disorder called Miller syndrome. (Source: NYT Health)
Source: NYT Health - January 20, 2022 Category: Consumer Health News Authors: Richard Sandomir Tags: Nickerson, Deborah (1954-2021) Genetics and Heredity DNA (Deoxyribonucleic Acid) Deaths (Obituaries) Human Genome Project National Human Genome Research Institute National Institutes of Health University of Washington Source Type: news

Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis
WEDNESDAY, Jan. 19, 2022 -- Dermatologists and patients with psoriatic disease have a positive view of a specialist-led model of care to improve cardiovascular disease (CVD) prevention, according to a study published online Jan. 19 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2022 Category: Pharmaceuticals Source Type: news

CVD Preventive Med Use Down During COVID-19 Pandemic CVD Preventive Med Use Down During COVID-19 Pandemic
Use of medications to manage cardiovascular disease risk factors significantly decreased during the COVID-19 pandemic in the UK and has not returned to prepandemic levels, a new study shows.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 19, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

USPSTF: Individualize Counseling for Primary Prevention of CVD
TUESDAY, Jan. 18, 2022 -- The U.S. Preventive Services Task Force (USPSTF) recommends that physicians individualize the decision to refer adults without known cardiovascular disease (CVD) risk factors to behavioral counseling interventions for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 18, 2022 Category: Pharmaceuticals Source Type: news

Prevention of CV and Renal Events in Patients With AF and DM Prevention of CV and Renal Events in Patients With AF and DM
What medical therapies are effective in preventing cardiovascular and renal events in patients with concomitant AF and diabetes? This paper reviews possible clinical approaches for these patients.Europace (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2022 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

High cholesterol: Key factor that can cause 'problems' for blood fat levels
CHOLESTEROL is a key indicator of your cardiovascular health, impacting your risk of developing heart disease. Certain groups are more likely to have poor cholesterol than others. (Source: Daily Express - Health)
Source: Daily Express - Health - January 15, 2022 Category: Consumer Health News Source Type: news

Comprehensive Approach Advised for Managing CV Risk in T2DM
FRIDAY, Jan. 14, 2022 -- A comprehensive approach is recommended for management of cardiovascular risk factors among patients with type 2 diabetes (T2D), according to an American Heart Association scientific statement published online Jan. 10 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 14, 2022 Category: Pharmaceuticals Source Type: news

SCCT commits to in-person annual meeting in July
The Society of Cardiovascular Computed Tomography (SCCT) will hold its 17t...Read more on AuntMinnie.comRelated Reading: Associations recommend CCTA as front-line test Finalists named for SCCT young investigator awards SCCT releases new consensus document on cardiovascular CT SCCT publishes consensus report on coronary CTA SCCT's 2021 annual meeting to be virtual (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 13, 2022 Category: Radiology Source Type: news

Doctors and Researchers Probe How COVID-19 Attacks the Heart
Experts have a decent grasp on how COVID-19 impacts cardiovascular health in the near term. The implications of long COVID, however, remain mysterious. (Source: The Scientist)
Source: The Scientist - January 12, 2022 Category: Science Tags: News & Opinion Source Type: news

Health Issues in Women Midlife Linked With Health Decline at 65 Health Issues in Women Midlife Linked With Health Decline at 65
Having specific health issues, including depressive symptoms and cardiovascular disease, as a middle-aged woman was associated with experiencing clinically important declines in health later in life.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 12, 2022 Category: Consumer Health News Tags: Internal Medicine News Source Type: news

Breastfeeding May Reduce Maternal Cardiovascular Risk
TUESDAY, Jan. 11, 2022 -- Among parous women, those who breastfeed may have a reduced risk for cardiovascular disease (CVD), according to a review published online Jan. 11 in Journal of the American Heart Association. Lena Tschiderer, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 11, 2022 Category: Pharmaceuticals Source Type: news

Cardiovascular Systems Recalls Wirion Embolic Protection Device Cardiovascular Systems Recalls Wirion Embolic Protection Device
The recall, identified by FDA as Class I, stems from complaints that the filter on the embolic protection device may break during retrieval, which could result in serious harm.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 10, 2022 Category: Cardiology Tags: Cardiology News Alert Source Type: news

More Vitamin D Not Better for Reducing Cancer or CVD Incidence More Vitamin D Not Better for Reducing Cancer or CVD Incidence
In a population of adults 60 years old and older with largely adequate vitamin D levels, vitamin supplementation failed to reduce the incidence of cancer or cardiovascular disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 10, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

How to Age Well, Superhero-Style
It’s not easy being a superhero: They have enemies. They have monumental tasks to accomplish. They’re constantly battered. Beyond those dangers, however, they also practice several healthy behaviors that could carry them well into old age. That’s what a team of Australian researchers recently discovered, as published in the light-hearted Christmas 2021 issue of the journal The BMJ. During pandemic lockdowns, the researchers immersed themselves in the world of Marvel superheroes. Their goal was to discover what these champions are or are not doing well when it comes to keeping their minds and bodies health...
Source: TIME: Health - January 10, 2022 Category: Consumer Health News Authors: Galadriel Watson Tags: Uncategorized Source Type: news

AI could speed up CT lung cancer screening
An artificial intelligence (AI) algorithm performs comparably to radiologist...Read more on AuntMinnie.comRelated Reading: Shorter follow-up for lung lesions equals better outcomes Could scanning more Black people boost benefits of lung screening? CT lung cancer screening guidelines are changing Rural areas lack access to CT lung cancer screening AI predicts cardiovascular risk on LDCT lung cancer screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 10, 2022 Category: Radiology Source Type: news

How to live longer: The warm drink which protects against hypertension and heart disease
HEART DISEASE is one of the leading causes of death worldwide. Cardiovascular diseases claim more than 160,000 lives each year, according to the British Heart Foundation. High blood pressure, also known as hypertension, is one of the risk factors for developing heart disease. There's one drink that can protect against both of these health problems and thus boost longevity. (Source: Daily Express - Health)
Source: Daily Express - Health - January 9, 2022 Category: Consumer Health News Source Type: news

Ditching cigarettes for smokeless tobacco can help cut cardiovascular risks, study finds
Regular smokers are at heightened risk of developing cardiovascular disease, but crushing the butts in favor of a “smokeless” alternative like chewing tobacco, snuff or tobacco lozenges may go a long way toward bringing the danger down to a more normal level, a new UCLA-led study shows.The findings also indicate that the primary culprit in smokers ’ increased risk is not nicotine but other chemicals found in tobacco smoke. Both cigarettes and smokeless tobacco products contain large quantities of nicotine.The study,published today in the journal Nicotine and Tobacco Research, involved a team of resea...
Source: UCLA Newsroom: Health Sciences - January 8, 2022 Category: Universities & Medical Training Source Type: news

Heart Failure Imaging: Where Are We Now? Heart Failure Imaging: Where Are We Now?
Experts discuss the current role of imaging modalities, particularly TTE and CMR, in monitoring and diagnosing cardiovascular diseases that can lead to heart failure.American College of Cardiology & Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 7, 2022 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division...
Source: Johnson and Johnson - January 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

eGFR Slope Tracks Kidney Disease in Cardiovascular Trials eGFR Slope Tracks Kidney Disease in Cardiovascular Trials
A new review proposes using the slope of estimated glomerular filtration rate (eGFR) as a surrogate measure of chronic kidney disease progression in cardiovascular outcome trials.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - January 6, 2022 Category: Transplant Surgery Tags: Nephrology News Source Type: news

SGLT2 Inhibitors Improve Cardiovascular Outcomes Across Groups SGLT2 Inhibitors Improve Cardiovascular Outcomes Across Groups
A comprehensive meta-analysis finds cardiovascular improvement across age, sex, and race/ethnicity for high-risk individuals with type 2 diabetes and other CVD risk factors.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 6, 2022 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Midlife CV Conditions, Risk Factors Linked to Cognitive Decline
Most cardiovascular conditions more strongly linked to cognition among women (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 6, 2022 Category: Psychiatry Tags: Cardiology, Endocrinology, Gynecology, Internal Medicine, Neurology, Pathology, Psychiatry, Journal, Source Type: news

Midlife CV Conditions, Risk Factors Linked to Cognitive Decline
WEDNESDAY, Jan. 5, 2022 -- Midlife cardiovascular conditions and risk factors are associated with cognitive decline, with stronger associations for women, according to a study published online Jan. 5 in Neurology. Nan Huo, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 6, 2022 Category: Pharmaceuticals Source Type: news

Midlife CV Conditions Tied to Greater Cognitive Decline in Women Midlife CV Conditions Tied to Greater Cognitive Decline in Women
Even though men in midlife have more cardiovascular conditions and risk factors, these conditions put women more at risk for cognitive decline, new research suggests.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 5, 2022 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Cardiovascular risks may be worse for thinking, memory skills in middle-aged women
ROCHESTER, Minn. — A Mayo Clinic study shows heart conditions such as coronary artery disease and cardiovascular risk factors such as diabetes and high cholesterol have stronger association with decline in memory and thinking skills during midlife for women than men. That's despite a higher prevalence of those con ditions in men. The research is published in Neurology, the medical journal of the American Academy of Neurology. "It is well-known that men, compared to women, have… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - January 5, 2022 Category: Hospital Management Source Type: news

Lipid management to prevent cardiovascular disease
The clinical pathway for lipid management has been updated to include bempedoic acid to primary prevention and inclisiran into the secondary prevention pathway. (Source: NHS Networks)
Source: NHS Networks - January 5, 2022 Category: UK Health Source Type: news

New study highlights need for prevention efforts to address causes of cardiovascular disease in African Americans in Minnesota
ROCHESTER, Minn. — Minnesota has the lowest age-adjusted heart disease mortality in the U.S.; yet, African American adults 35 to 63 have nearly double the rate of death from cardiovascular disease, compared to their white counterparts. Findings of a new study show that basic health beliefs and demographics, such a s age, sex, marital status and level of education attained, were associated with the risk factors for cardiovascular disease. Of the study group, the prevalence of… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - January 4, 2022 Category: Hospital Management Source Type: news

Risk Factors for Heart Disease Tied to Patterns on Cardiac MRI
MONDAY, Jan. 3, 2022 -- There are independent associations for sex, age, and major vascular risk factors (VRFs) with cardiovascular magnetic resonance (CMR) radiomics phenotypes, according to a study published online Dec. 22 in Frontiers in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 3, 2022 Category: Pharmaceuticals Source Type: news

Statins: The symptom when touching your abdomen that could be a side effect for concern
STATINS are a common medicine, used by thousands across the country to treat conditions such as cardiovascular disease, high cholesterol, angina, heart attacks and strokes. They can cause side effects like many other medicines that detrimentally impact your health. (Source: Daily Express - Health)
Source: Daily Express - Health - January 3, 2022 Category: Consumer Health News Source Type: news

Influenza Vaccination After Myocardial Infarction Influenza Vaccination After Myocardial Infarction
This study suggests that influenza vaccination early after myocardial infarction or in high-risk coronary heart disease may provide protection against future cardiovascular events and death.Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 3, 2022 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Dapagliflozin in Patients With CKD, With and Without HF Dapagliflozin in Patients With CKD, With and Without HF
Heart failure is common in patients with chronic kidney disease. Might the SGLT-2 inhibitor dapagliflozin reduce the risk of kidney failure and cardiovascular death in these patients?JACC: Heart Failure (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 3, 2022 Category: Intensive Care Tags: Cardiology Journal Article Source Type: news

Young Newlywed Couples Share Similar CV Risk Factors Young Newlywed Couples Share Similar CV Risk Factors
Newlyweds may have more in common than hobbies or love. A new study found a concordance of cardiovascular risk factors as well.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 30, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Hypertension With Right Subclavian Plaque Tied to CV Events Hypertension With Right Subclavian Plaque Tied to CV Events
The prevalence of right subclavian plaques was a strong predictor of future cardiovascular events in patients with hypertension.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 30, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

CV Events in PCOS: Is the Debate Settled for Good? CV Events in PCOS: Is the Debate Settled for Good?
Has recent research provided a conclusive answer as to whether women with PCOS have an increased incidence of cardiovascular events?Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 30, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant
NEW BRUNSWICK, N.J., December 30, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a homologous (same vaccine) booster shot of the Johnson & Johnson COVID-19 vaccine (Ad26.COV2.S) demonstrated 85 percent effectiveness against COVID-19-related hospitalization. The study, conducted by the South African Medical Research Council (SAMRC), showed that the Johnson & Johnson booster reduced the risk of hospitalization from COVID-19 among healthcare workers in South Africa after Omicron became the dominant var...
Source: Johnson and Johnson - December 30, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Submits Biologics License Application to U.S. FDA Seeking Approval of Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
RARITAN, N.J., December 29, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval of teclistamab for the treatment of patients with relapsed or refractory (R/R) multiple myeloma. Teclistamab is an investigational, off-the-shelf, T-cell redirecting, bispecific antibody targeting both B-cell maturation antigen (BCMA) and CD3.“Despite all the gains that have been made in treating multiple myeloma, the unmet need still remains very high. Our relentless pursuit of tre...
Source: Johnson and Johnson - December 29, 2021 Category: Pharmaceuticals Tags: Latest News Source Type: news

Effect of childhood maltreatment on cardiovascular response habitation to repeated psychosocial stress - Zhang Y, Lu W.
Childhood maltreatment as an early-life stress leads to cardiovascular stress response dysregulation manifested by either exaggerated or blunted stress responses. However, little is known how childhood maltreatment affects cardiovascular response habituati... (Source: SafetyLit)
Source: SafetyLit - December 28, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

COVID-19 Elevates Diabetes, Cardiovascular Disease Risk COVID-19 Elevates Diabetes, Cardiovascular Disease Risk
Data from more than half a million UK residents infected with COVID-19 showed significant increases in the incidence of diabetes and cardiovascular disease events fpr months following infection.First Look (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - December 28, 2021 Category: Intensive Care Tags: Diabetes & Endocrinology News Source Type: news

Sex Hormone-Binding Globulin May Be Biomarker for CVD Risk in Men
TUESDAY, Dec. 28, 2021 -- Men with lower concentrations of total testosterone do not have an increased risk for cardiovascular events, while lower concentration of sex hormone-binding globulin (SHBG) is associated with a higher incidence of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2021 Category: Pharmaceuticals Source Type: news

Factors for Nativity-Related Disparities in Preeclampsia May Vary by Race
MONDAY, Dec. 27, 2021 -- After adjustment for sociodemographic and cardiovascular risk factors, nativity-related disparities in preeclampsia persist among non-Hispanic Black women but not among Hispanic and non-Hispanic White women, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 27, 2021 Category: Pharmaceuticals Source Type: news

Childhood violence exposure, inflammation, and cardiometabolic health - Finegood ED, Miller GE.
Exposure to interpersonal violence during childhood, a severe and often traumatic form of social stress, is an enduring problem that an emerging body of work suggests may be relevant to cardiometabolic health and the progression of cardiovascular disease (... (Source: SafetyLit)
Source: SafetyLit - December 24, 2021 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

FDA approves add-on therapy to lower cholesterol among certain high-risk adults
FDA has approved Leqvio (inclisiran) injection as a treatment to be used along with diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 22, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

High-Dose IV Iron Reduces MI in Patients on Hemodialysis
WEDNESDAY, Dec. 22, 2021 -- For patients on maintenance hemodialysis, high-dose versus low-dose intravenous (IV) iron can help reduce the risk for myocardial infarction (MI), according to a study published online Dec. 7 in Cardiovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 22, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Two New Indications for XARELTO ® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
RARITAN, NJ, Dec. 20, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved two pediatric indications for XARELTO® (rivaroxaban): the treatment of venous thromboembolism (VTE, or blood clots) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of initial parenteral (injected or intravenous) anticoagulant treatment; and thromboprophylaxis (prevention of blood clots and blood-clot related events) in children aged two years and older with congenital heart disease w...
Source: Johnson and Johnson - December 21, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news